Global and United States Meningococcal Conjugate Market Report & Forecast 2022-2028

Global and United States Meningococcal Conjugate Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Meningococcal Conjugate Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million) Introduction
1.2 Global Meningococcal Conjugate Outlook 2017 VS 2022 VS 2028
1.2.1 Global Meningococcal Conjugate Market Size for the Year 2017-2028
1.2.2 Global Meningococcal Conjugate Market Size for the Year 2017-2028
1.3 Meningococcal Conjugate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Meningococcal Conjugate in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Meningococcal Conjugate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Meningococcal Conjugate Market Dynamics
1.4.1 Meningococcal Conjugate Industry Trends
1.4.2 Meningococcal Conjugate Market Drivers
1.4.3 Meningococcal Conjugate Market Challenges
1.4.4 Meningococcal Conjugate Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Meningococcal Conjugate by Type
2.1 Meningococcal Conjugate Market Segment by Type
2.1.1 Menactra
2.1.2 Menveo
2.1.3 NeisVac-C
2.1.4 Nimenrix
2.1.5 Others
2.2 Global Meningococcal Conjugate Market Size by Type (2017, 2022 & 2028)
2.3 Global Meningococcal Conjugate Market Size by Type (2017-2028)
2.4 United States Meningococcal Conjugate Market Size by Type (2017, 2022 & 2028)
2.5 United States Meningococcal Conjugate Market Size by Type (2017-2028)
3 Meningococcal Conjugate by End User
3.1 Meningococcal Conjugate Market Segment by End User
3.1.1 Children
3.1.2 Preteens or Teens
3.1.3 Adults
3.2 Global Meningococcal Conjugate Market Size by End User (2017, 2022 & 2028)
3.3 Global Meningococcal Conjugate Market Size by End User (2017-2028)
3.4 United States Meningococcal Conjugate Market Size by End User (2017, 2022 & 2028)
3.5 United States Meningococcal Conjugate Market Size by End User (2017-2028)
4 Global Meningococcal Conjugate Competitor Landscape by Company
4.1 Global Meningococcal Conjugate Market Size by Company
4.1.1 Top Global Meningococcal Conjugate Companies Ranked by Revenue (2021)
4.1.2 Global Meningococcal Conjugate Revenue by Player (2017-2022)
4.2 Global Meningococcal Conjugate Concentration Ratio (CR)
4.2.1 Meningococcal Conjugate Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Meningococcal Conjugate in 2021
4.2.3 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Meningococcal Conjugate Headquarters, Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million) Type
4.3.1 Global Meningococcal Conjugate Headquarters and Area Served
4.3.2 Global Meningococcal Conjugate Companies Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Meningococcal Conjugate Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Meningococcal Conjugate Market Size by Company
4.5.1 Top Meningococcal Conjugate Players in United States, Ranked by Revenue (2021)
4.5.2 United States Meningococcal Conjugate Revenue by Players (2020, 2021 & 2022)
5 Global Meningococcal Conjugate Market Size by Region
5.1 Global Meningococcal Conjugate Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Meningococcal Conjugate Market Size by Region (2017-2028)
5.2.1 Global Meningococcal Conjugate Market Size by Region: 2017-2022
5.2.2 Global Meningococcal Conjugate Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Meningococcal Conjugate Market Size YoY Growth 2017-2028
6.1.2 North America Meningococcal Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Meningococcal Conjugate Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Meningococcal Conjugate Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Meningococcal Conjugate Market Size YoY Growth 2017-2028
6.3.2 Europe Meningococcal Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Meningococcal Conjugate Market Size YoY Growth 2017-2028
6.4.2 Latin America Meningococcal Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Meningococcal Conjugate Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Meningococcal Conjugate Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Details
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
7.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2017-2022)
7.1.5 Sanofi Pasteur Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Details
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Meningococcal Conjugate Introduction
7.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2017-2022)
7.2.5 Pfizer Recent Development
7.3 Glaxo Smith Kline
7.3.1 Glaxo Smith Kline Company Details
7.3.2 Glaxo Smith Kline Business Overview
7.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
7.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2017-2022)
7.3.5 Glaxo Smith Kline Recent Development
7.4 Hualan Biological Engineering
7.4.1 Hualan Biological Engineering Company Details
7.4.2 Hualan Biological Engineering Business Overview
7.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
7.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2017-2022)
7.4.5 Hualan Biological Engineering Recent Development
7.5 JN International Medical Corporation
7.5.1 JN International Medical Corporation Company Details
7.5.2 JN International Medical Corporation Business Overview
7.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
7.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2017-2022)
7.5.5 JN International Medical Corporation Recent Development
7.6 Baxter International
7.6.1 Baxter International Company Details
7.6.2 Baxter International Business Overview
7.6.3 Baxter International Meningococcal Conjugate Introduction
7.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2017-2022)
7.6.5 Baxter International Recent Development
7.7 Merck
7.7.1 Merck Company Details
7.7.2 Merck Business Overview
7.7.3 Merck Meningococcal Conjugate Introduction
7.7.4 Merck Revenue in Meningococcal Conjugate Business (2017-2022)
7.7.5 Merck Recent Development
7.8 Serum Institute of India
7.8.1 Serum Institute of India Company Details
7.8.2 Serum Institute of India Business Overview
7.8.3 Serum Institute of India Meningococcal Conjugate Introduction
7.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2017-2022)
7.8.5 Serum Institute of India Recent Development
7.9 Biomed
7.9.1 Biomed Company Details
7.9.2 Biomed Business Overview
7.9.3 Biomed Meningococcal Conjugate Introduction
7.9.4 Biomed Revenue in Meningococcal Conjugate Business (2017-2022)
7.9.5 Biomed Recent Development
7.10 Novartis
7.10.1 Novartis Company Details
7.10.2 Novartis Business Overview
7.10.3 Novartis Meningococcal Conjugate Introduction
7.10.4 Novartis Revenue in Meningococcal Conjugate Business (2017-2022)
7.10.5 Novartis Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Meningococcal Conjugate Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Meningococcal Conjugate Market Trends
Table 3. Meningococcal Conjugate Market Drivers
Table 4. Meningococcal Conjugate Market Challenges
Table 5. Meningococcal Conjugate Market Restraints
Table 6. Global Meningococcal Conjugate Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Meningococcal Conjugate Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Meningococcal Conjugate Market Size by End User: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Meningococcal Conjugate Market Size by End User: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Meningococcal Conjugate Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Meningococcal Conjugate Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Meningococcal Conjugate Revenue Share by Player, 2017-2022
Table 13. Global Meningococcal Conjugate Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2021)
Table 15. Top Players of Meningococcal Conjugate in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Meningococcal Conjugate Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Meningococcal Conjugate Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Meningococcal Conjugate Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Meningococcal Conjugate Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Meningococcal Conjugate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Meningococcal Conjugate Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Meningococcal Conjugate Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Meningococcal Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Meningococcal Conjugate Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Meningococcal Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Meningococcal Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Meningococcal Conjugate Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Sanofi Pasteur Company Details
Table 31. Sanofi Pasteur Business Overview
Table 32. Sanofi Pasteur Meningococcal Conjugate Product
Table 33. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 34. Sanofi Pasteur Recent Development
Table 35. Pfizer Company Details
Table 36. Pfizer Business Overview
Table 37. Pfizer Meningococcal Conjugate Product
Table 38. Pfizer Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 39. Pfizer Recent Development
Table 40. Glaxo Smith Kline Company Details
Table 41. Glaxo Smith Kline Business Overview
Table 42. Glaxo Smith Kline Meningococcal Conjugate Product
Table 43. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 44. Glaxo Smith Kline Recent Development
Table 45. Hualan Biological Engineering Company Details
Table 46. Hualan Biological Engineering Business Overview
Table 47. Hualan Biological Engineering Meningococcal Conjugate Product
Table 48. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 49. Hualan Biological Engineering Recent Development
Table 50. JN International Medical Corporation Company Details
Table 51. JN International Medical Corporation Business Overview
Table 52. JN International Medical Corporation Meningococcal Conjugate Product
Table 53. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 54. JN International Medical Corporation Recent Development
Table 55. Baxter International Company Details
Table 56. Baxter International Business Overview
Table 57. Baxter International Meningococcal Conjugate Product
Table 58. Baxter International Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 59. Baxter International Recent Development
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Meningococcal Conjugate Product
Table 63. Merck Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 64. Merck Recent Development
Table 65. Serum Institute of India Company Details
Table 66. Serum Institute of India Business Overview
Table 67. Serum Institute of India Meningococcal Conjugate Product
Table 68. Serum Institute of India Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 69. Serum Institute of India Recent Development
Table 70. Biomed Company Details
Table 71. Biomed Business Overview
Table 72. Biomed Meningococcal Conjugate Product
Table 73. Biomed Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 74. Biomed Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Meningococcal Conjugate Product
Table 78. Novartis Revenue in Meningococcal Conjugate Business (2017-2022) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Conjugate Product Picture
Figure 2. Global Meningococcal Conjugate Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Meningococcal Conjugate Market Size 2017-2028 (US$ Million)
Figure 4. United States Meningococcal Conjugate Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Meningococcal Conjugate Market Size 2017-2028 (US$ Million)
Figure 6. United States Meningococcal Conjugate Market Share in Global 2017-2028
Figure 7. Meningococcal Conjugate Report Years Considered
Figure 8. Product Picture of Menactra
Figure 9. Product Picture of Menveo
Figure 10. Product Picture of NeisVac-C
Figure 11. Product Picture of Nimenrix
Figure 12. Product Picture of Others
Figure 13. Global Meningococcal Conjugate Market Share by Type in 2022 & 2028
Figure 14. Global Meningococcal Conjugate Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Meningococcal Conjugate Market Share by Type (2017-2028)
Figure 16. United States Meningococcal Conjugate Market Share by Type in 2022 & 2028
Figure 17. United States Meningococcal Conjugate Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Meningococcal Conjugate Market Share by Type (2017-2028)
Figure 19. Product Picture of Children
Figure 20. Product Picture of Preteens or Teens
Figure 21. Product Picture of Adults
Figure 22. Global Meningococcal Conjugate Market Share by End User in 2022 & 2028
Figure 23. Global Meningococcal Conjugate Market Size by End User (2017-2028) & (US$ Million)
Figure 24. Global Meningococcal Conjugate Market Share by End User (2017-2028)
Figure 25. United States Meningococcal Conjugate Market Share by End User in 2022 & 2028
Figure 26. United States Meningococcal Conjugate Market Size by End User (2017-2028) & (US$ Million)
Figure 27. United States Meningococcal Conjugate Market Share by End User (2017-2028)
Figure 28. North America Meningococcal Conjugate Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Meningococcal Conjugate Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Meningococcal Conjugate Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Meningococcal Conjugate Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Meningococcal Conjugate Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Meningococcal Conjugate Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 58. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 59. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 60. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 61. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 62. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 63. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 64. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs